The government had set up a committee headed by Secretary, Department of Health Research, to look into the issues of bulk drugs/active pharmaceutical ingredients (API).
"The recommendations of the committee are being examined in consultation with the stakeholders. Once they are implemented, it would provide a road map for strengthening the bulk drug/API industry", Minister of Chemicals and Fertilisers Ananth Kumar said in a reply to Lok Sabha.
The committee was mandated to study the whole issue of APIs of critical importance by identifying important APIs and then work out a package of interventions and concessions to build the domestic production capabilities and examine the cost implications, Kumar added.